MedPath

effect of potassium permanganate solution on diabetic foot

Not Applicable
Recruiting
Conditions
Diabetes.
????? ?? ????? ????????? ? ???? ????? ?????
ICDE-10
Registration Number
IRCT20221015056180N1
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria

Outpatient referral
Patients with type 2 diabetes
Diabetic foot ulcer with Wagner score 1 or 2
Presence of chronic neuropathic and non-ischemic diabetic foot ulcer that has been present for at least 3 months
Patients in the age range of 18 to 65 years

Exclusion Criteria

The presence of ischemia symptoms in the lower limbs and ankle-brachial index and toe-brachial index (ABI, TBI) less than 0.7
Advanced wound infection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ocal infection of diabetic foot ulcer. Timepoint: Investigation of wound infection at the beginning of the study and then on days 7, 14 and 21. Method of measurement: Based on the examination and determining the Wagner score of diabetic foot ulcer.;Size of diabetic foot ulcer. Timepoint: Measurement of diabetic foot ulcer at the beginning of the study and then on days 7, 14 and 21. Method of measurement: With examination and caliper device.;Granulation tissue formation. Timepoint: Examination of granulation tissue formation at the beginning of the study and then on days 7, 14 and 21. Method of measurement: Based on examination of diabetic foot ulcer.
Secondary Outcome Measures
NameTimeMethod
The duration of complete healing of diabetic foot ulcer. Timepoint: At the beginning of the study and then on days 7, 14 and 21. Method of measurement: Based on the examination of the attending physician.
© Copyright 2025. All Rights Reserved by MedPath